Pharmafile Logo
Pharmafocus logo
Advanced Search

PMCPA

Showing 15 posts of 81 posts found.

sanofi image

Sanofi escapes most serious censure

December 13, 2013
Medical Communications, Sales and Marketing ABPI, Lyxumia, PMCPA, Sanofi, censure

Sanofi has been cleared of the most serious breach of the ABPI Code of Practice – despite appearing to offer …

News
GSK logo

GSK: no Votrient Code breaches

November 4, 2013
Medical Communications, Sales and Marketing GSK, PMCPA, Pfizer

News
sanofi image

PMCPA: Sanofi ‘discredited pharma’

October 28, 2013
Medical Communications, Sales and Marketing ABPI, PMCPA, Sanofi, breach

Sanofi has lowered the public’s confidence in the pharma industry, according to the PMCPA, which enforces the ABPI Code of …

News
Bayer image

Bayer slammed for ‘nightcaps’

September 26, 2013
Medical Communications, Sales and Marketing ABPI, Bayer, PMCPA

Bayer has come under fire from the PMCPA for providing late-night drinks to delegates at a conference in Amsterdam, exceeding …

News
Twitter iPhone

FDA spends big on social media outlook

September 20, 2013
Medical Communications, Sales and Marketing FDA, Facebook, PMCPA, Psoriasis 360, Twitter

News
Gedeon richter image

Gedeon Richter named and shamed

September 9, 2013
Medical Communications, Sales and Marketing ABPI, Gedeon Richter, PMCPA

Gedeon Richter (UK) has been named and shamed in advertisements by the PMCPA, which rules on breaches of the ABPI …

News
Merck image

MSD cleared by PMCPA

July 23, 2013
Medical Communications, Sales and Marketing ABPI, MSD, Merck, PMCPA, code

Merck Sharp Dohme has been found not guilty of breaching two clauses in the ABPI Code of Practice – including …

News
januvia image

MSD takes Januvia rap

July 9, 2013
Medical Communications, Sales and Marketing Januvia, MSD, Merck, PMCPA

Merck Sharp & Dohme has been censured by the PMCPA for failing to uphold standards in the way it promoted …

News
Merck Serono image

Merck Serono censured over calls

June 25, 2013
Medical Communications, Sales and Marketing ABPI, Erbitux, Merck Serono, PMCPA

A Merck Serono medical representative has been accused of ‘harassing’ an anonymous health professional by requesting a meeting every month …

News
Leo Pharma image

Leo exaggerates Picato properties

June 14, 2013
Medical Communications, Sales and Marketing ABPI, LEO Pharma, PMCPA

Leo Pharma has been censured by the PMCPA for not maintaining high standards over an advertisement that overreached itself when …

News

Boehringer’s online PMCPA breach

April 25, 2013
Medical Communications, Research and Development, Sales and Marketing ABPI, AF, Boehringer, PMCPA

Boehringer Ingelheim has failed to uphold high standards, according to the PMCPA, which enforces the ABPI Code of Practice, over …

News
abpi_reception

Ten pharma firms censured

March 28, 2013
Medical Communications, Sales and Marketing ABPI, PMCPA

Ten pharma companies have been found guilty by the PMCPA of failing to maintain high standards over their involvement in …

News

Pulse mistake costs Astellas

March 15, 2013
Medical Communications, Sales and Marketing ABPI, Astellas, PMCPA, pulse

A mistake by medical journal Pulse has landed Astellas Pharma in hot water with the PMCPA, enforcers of the ABPI …

News
Roche image

Roche censured for drunken conference antics

February 21, 2013
Medical Communications, Sales and Marketing ABPI, PMCPA, Roche

The conduct of senior Roche employees has come under the spotlight following a complaint about drunkenness and poor behaviour at …

News
Xarelto image

Bayer cleared of Xarelto ‘breaches’

January 17, 2013
Medical Communications, Sales and Marketing Bayer, PMCPA, Xarelto

Bayer has been found not guilty of making multiple breaches of the ABPI Code of Practice following an anonymous complaint …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026